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Abstract 
Objective: Rapid detection and accurate diagnosis are very important in managing active tuberculosis because they 
provide an advantage in preventing further disease transmission. In accordance with the recommendation of the 
World Health Organization, the Indonesian Tuberculosis Control Program uses the acid fast bacilli (AFB) smear and 
Chest X-ray methods as the primary methods for detecting tuberculosis, especially in new cases of suspected tuber-
culosis. The genus Mycobacterium has many species, strains, and variants, and their natural differences may affect the 
clinical outcome of the diseases they induce. The purpose of this study was to assess different tuberculosis detection 
methods as part of serial tests and determine the best diagnostic approach for detecting active lung tuberculosis in 
Indonesia.
Results: This study used clinical samples from tuberculosis patients and assessed them using a series of tests, aiming 
to increase the sensitivity of active tuberculosis detection. Some samples that yielded negative results in the AFB 
smear test were detected as positive for Mycobacterium tuberculosis using the nucleic acid amplification test, with a 
sensitivity of 83.1%. Additionally, nucleic acid amplification also detected positive results among samples assessed as 
M. tuberculosis-negative using the culture method, this method yielded the same results as the Gene Xpert test.
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Introduction
Tuberculosis (TB) is a major global health problem; this 
disease has caused more deaths than any other infectious 
disease over the last 200  years [1]. The number of TB 
deaths remains unacceptably high. To combat this, a timely 
diagnosis and the application of appropriate treatment are 
required [2]. TB infection is caused by members of the 
Mycobacterium tuberculosis Complex (MTBC), which 
is the major group responsible for human pulmonary 
infections. This group is composed of anaerobic, acid-fast, 
slow-growing bacteria, and it can be difficult to deter-
mine the species responsible for specific TB cases [3]. TB 
usually appears several years after infection, often when 
the immune system function is decreased by some other 
cause [4]. The transmission of TB occurs by inhalation of 
infectious droplet nuclei containing viable bacilli (aerosol 
spread). Factors influencing the chance of transmission 
include the bacillary load of the source case, e.g., higher 
transmission occurs from active pulmonary cases who are 
sputum smear-positive or who display lung cavities on a 
chest radiograph, as well as the proximity and duration of 
exposure [5]. Overall, the risk of infection among house-
hold contacts of TB patients is around 30% [6]. Trans-
mission is rapidly reduced with effective treatment [7]. 
Therefore, early TB diagnosis and management is critical.
An acid-fast bacilli (AFB) smear is used to screen 
for new TB infection, and this method requires fresh 
sputum from patients as input samples. Previous work 
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in Brazil on the accuracy of the AFB smear method 
reported that this test has a sensitivity of 36% and a 
specificity of 100% [8].
The conventional culture method for Mycobacterium 
tuberculosis is a more sensitive technique by which 
to detect TB compared with AFB smears, but, due 
to the slow growth of the organism, sputum cultures 
take 4–6  weeks to become positive on solid media 
and 10–21  days in liquid media. Solid culture is usu-
ally performed on Lowenstein–Jensen (LJ), Ogawa, or 
Middlebrook 7H10/11. Liquid culture of M. tuberculo-
sis is more sensitive and rapid than solid culture but is 
prone to contamination in some laboratories, so it is 
best to use both methods in conjunction [9].
The significant advance in the diagnosis of TB in 
the last decade has been the advent of the Gene Xpert 
MTB/RIF (Gene Xpert) test. The accuracy of the Gene 
Xpert test offers a significant increase in terms of 
diagnostic sensitivity, even when it is deployed selec-
tively, i.e., among only smear-negative presumptive 
TB patients. However, because this method is limited 
by the expensive equipment required, the Gene Xpert 
assay is still rarely used in countries with a high HIV/
TB prevalence [10].
The detection of M. tuberculosis in clinical samples 
is generally less sensitive than the detection of other 
pathogens due to the relatively low numbers of bacilli 
present [11]. Despite this limitation, the nucleic acid 
amplification method has the potential to be used for 
differentiating the species and strains of isolates and 
clinical specimens [12].
In Indonesia, new patient TB is initially diagnosed by 
the AFB smear and X-ray methods. Following positive 
results from these tests, the patient status is further 
monitored by the culture method during the treat-
ment period. Traditional TB control focused on the 
identification and treatment of sputum smear-positive 
TB patients, who are considered the most infectious 
cases. In a policy change in 2010, the World Health 
Organization recommended that two sputum samples 
are sufficient, rather than the standard three samples 
(spot-morning-spot) that had been recommended for 
several decades [13]. Repeated testing may still be war-
ranted, so it is important to establish a good diagnostic 
method for detecting active lung TB.
The methods for MTBC detection have variable 
accuracy, and a combination of serial tests is expected 
to increase the overall accuracy of the diagnostic 
method. Therefore, this study investigated the diag-
nostic quality of applying serial MTBC detection tests 
to detecting active lung TB in Indonesia.
Main text
Methods
This study was conducted on sputum samples from pul-
monary TB patients. All samples were examined by serial 
tests: smear microscopy, culture method, Gene Xpert 
assay, and PCR assay. All methods were used to evaluate 
the sensitivity and specificity for detecting active TB.
Patients
From September to December 2016, sputum samples 
were collected 96 samples by random sampling which 
collected from minimum representative samples of 
pulmonary active TB patients with positive and nega-
tive AFB results, who were either untreated or treated 
with anti-TB drugs, in the Dr. Soetomo Academic Hos-
pital, Surabaya, Indonesia. These samples were then 
examined using smear microscopy, culture, PCR, and 
the Gene Xpert assay. The Gene Xpert assay was used 
for the screening of antibiotic-resistant cases. For each 
patient, the sex (male or female), age group (< 30  years 
old; 30–60 years old; or > 60 years old), and length of drug 
treatment (< 6 months or > 6 months) were recorded.
Smear microscopy
The sputum samples were first decontaminated with 4% 
NaOH as previously described [14]. After decontamina-
tion, a circular smear of each sputum sample was made 
on slides with a 2 × 3-cm2 surface area. For the AFB 
smears, the Ziehl-Neelsen staining method was used as 
previously described [15, 16].
Mycobacterial culture
The culture method was performed using Lowenstein-
Jensen and Middlebrook media (Merck, Germany) [17]. 
This method requires around 3–4 weeks for visible colo-
nies to grow. After the colonies appeared, they were sub-
jected to the SD Bioline MPT64 antigen test (Standard 
Diagnostic, Germany) to identify the MTBC species.
DNA extraction
DNA extraction was conducted using the Qiagen DNA 
extraction kit  (DNeasy®, Cat. No. 69504). Extracted DNA 
was amplified using PCR (MJ MiniTM Thermal cycle, 
BioRed). The primers used were F: 5ʹ-CGC GCT TTT 
GTT TGG AGA GTT TGA TCC TGG-3ʹ and R: 5ʹ-GAG 
AAA GGA GAT CCA GCC GC-3ʹ. These primers were 
designed using the genetic program MTBC H37Rv ATCC 
27294 with a 1537-bp specific region on the MTBC 16S 
rRNA gene as a target. The primers were added to the 
PCR Mix  (KapaBiosystem® Ready Mix).
Page 3 of 5Sari et al. BMC Res Notes          (2019) 12:313 
PCR amplification
Amplification was initiated with denaturation at 94  °C 
for 20 s, followed by annealing at 53.8 °C for 10 s, and 
extension at 72  °C for 30  s [16]. The PCR results were 
visualized using electrophoresis followed by UV tran-
sillumination. The 16S rRNA gene of M. tuberculosis 
H37Rv strain ATCC 27294 was used as a positive con-
trol, and PCR mix  (KapaBiosystem® Ready Mix) with-
out DNA was used as a negative control.
Gene Xpert
The Gene Xpert MTB/RIF test (Cepheid, CA, USA) was 
performed in the Department of Clinical Microbiology, 
Dr. Soetomo Academic Hospital in accordance with the 
standardized procedure provided in the accompanying 
manual [18].
Statistical analysis
The sensitivity and specificity of serial tests for TB 
detection were conducted by applying the culture 
method as the Gold Standard and performing t-tests in 
a 2 × 2 table analysis.
Results
We obtained sputum samples from 96 pulmonary TB 
patients in Indonesia. These patients included 56 men 
(58.33%) and 40 women (41.67%). Most of the patients 
were aged around 30–60 years old (78.13%), and most 
of the patients had a drug treatment history of less than 
6 months (89.6%).
All the samples were tested using AFB smears, the 
culture method, Gene Xpert assays, and nucleic acid 
amplification. The sensitivity of these serial tests was 
calculated based on the culture method as the Gold 
Standard. Samples with negative AFB smear results 
were often positively detected using a nucleic ampli-
fication test, with a sensitivity of 83.1%. The positivity 
result of PCR in negative AFB smear same with Gene 
Xpert (Table  1). On the other hand, negative culture 
result can be detected by PCR until 50 samples with 
specificity 79.17%. Furthermore, the amplification of 
nucleic acid similarly yielded positive results for sam-
ples that had negative culture results. These joint 
results were comparable to the Gene Xpert results.
Discussion
The AFB smear detects all acid-fast bacilli, includ-
ing Mycobacterium tuberculosis and Non-Tuberculous 
Mycobacteria (NTM), it makes AFB smear not specific. 
Centrifugation and filtration can increase the concen-
tration of sample to improve sensitivity of AFB smear 
[19], although there is AFB smear without concentra-
tion which is used and can cause many limitations. 
Additionally, this method still has low sensitivity for 
confirming MTBC infection [20]. Notably, a single 
AFB-positive sputum smear is now considered suffi-
cient for a TB diagnosis [21, 22].
The culture method is necessary to confirm drug sus-
ceptibility, particularly for second-line drugs in cases of 
multi-drug resistance (i.e., MDR TB). The application of 
M. tuberculosis culture and phenotypic drug suscepti-
bility testing (DST) requires significant training, infra-
structure, strict infection control, and on-going quality 
assurance; however, in most countries, these are avail-
able in only regional reference laboratories. In this study, 
results based on only the culture method showed low 
positivity, which could be due to the requirements of this 
method for appropriate media, proper technique, and 
high quality specimens. Before the culture method was 
performed, the specimens were decontaminated, which 
required careful handling because a NaOH concentra-
tion that is too high will kill the bacteria but one that is 
too low will allow sample contamination [23]. Other 
study said culture is still as Gold standard for diagnosis of 
TB, but it is more difficult and may not be available, this 
method also required as much as 6–8 weeks to collect the 
result [24].
In the present study, they found 6.6% of rifampicin 
resistant strains (DST proven) revealing no mutations 
of rifampicin in the RRDR of rpoB gene in Gene Xpert 
assay, even if has a specific cartridge that was developed 
to simultaneously detect M. tuberculosis and determine 
its resistance to rifampicin [25, 26]. However, many 
of the patients diagnosed based on Gene Xpert assay 
results would also have been appropriately diagnosed 
based on chest X-ray findings or on clinical findings 
consistent with TB, and the extent to which the use 
of the Gene Xpert assay will increase the number of 
detected TB cases is not yet clear. Theoretical studies 
Table 1 Results of  serial tests from  the  tuberculosis 
patients




 Positive 59 20 Sensitivity: 83.1%
 Negative 12 5 Specificity: 20%
Gene Xpert
 Positive 59 21 Sensitivity: 63.64%
 Negative 12 4 Specificity: 16.67%
Culture
 Positive 22 5 Sensitivity: 30.56%
 Negative 50 19 Specificity: 79.17%
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suggest that the application of this test will improve 
treatment targeting, with fewer patients who do not 
have TB incorrectly started on anti-TB treatment and 
a greater number of smear-negative “true TB” cases 
detected [27].
Nucleic acid amplification tests (NAAT), in which 
the most important one is the polymerase chain reac-
tion (PCR), have emerged as powerful tools for rapid 
detection of the mycobacteria in clinical and research 
specimens [24]. The PCR method applied in this study 
used the 16S rRNA gene. Although both are molecu-
lar methods, this test is distinct from the method used 
by the Gene Xpert assay. Notably, the PCR method 
can identify cases of pulmonary TB infection from 
sputum samples more specifically compared with the 
other available methods [28]. The 16S rRNA gene is a 
universal gene in bacteria; this gene is functional and 
contains both a conserved region and a variable region 
[29]. Methods using this target gene allow the specific 
design of primers for the MTBC 16S rRNA gene; thus, 
only cases with MTBC infection yield positive results.
Some of the results obtained by other methods are 
not same as that by PCR because of the weakness of 
each method, so the serial test is important to deter-
mine and to distinguish the pulmonary TB infection 
from other diseases. Notably, it is best to apply all these 
methods as TB diagnostic tests before anti-TB drug 
treatment is begun [30]. In Indonesia, the diagnosis of 
new TB cases typically still occurs without the applica-
tion of the Gene Xpert or PCR methods, although the 
Gene Xpert assay is used in Indonesia to confirm active 
TB in drug-resistant cases.
In conclusion, the application of serial tests as a new 
algorithm for MTBC detection can increase the valid-
ity of the TB diagnostic method, and this will better 
guide the management of TB treatment. The previous 
algorithm consists of AFB smear, culture method, and 
nucleic acid amplification test [31]. Our results provide 
a good comparison among methods, improve and indi-
cate that the use of serial detection tests can identify 
cases that might otherwise fail to be detected.
Limitations
This is the first study to investigate the molecular detec-
tion using a gene region that could be used to identify 
active TB cases but is insufficient for other uses, i.e., 
detecting the drug resistance of TB.
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